Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new revision label v3.3.2 added and the previous v3.3.1 removed, indicating a minor update to the document. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.3.1 is now displayed on the page, replacing the previous v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding status notice banner was removed from the Study Details page (NCT03278626). Core trial information, eligibility criteria, and study plan remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant changes detected on the page; the study title, details, eligibility criteria, and listed locations appear unchanged. The content is visually similar to the previous version with no additions or deletions affecting user actions.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check70 days agoChange DetectedUpdate: revision tag changed from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.